J&J to unload Indian consumer brands; Omega taps new U.K. agency; Bayer moves media-buying business;

> Johnson & Johnson ($JNJ) is selling the Indian rights to two consumer brands, Savlon antiseptic soap and Shower to Shower talcum powder, domestic media reports. Report

> Omega Pharma, currently in the process of selling itself, tapped a new agency to handle its U.K. and Ireland accounts; The Corner nabbed the business. Report

> Bayer moved a $11 million media account in Australia from Mediacom to PHD after a global review; worldwide, Mediacom kept four markets and PHD ended up with the other four, including Australia, Mumbrella says. Report

> ViiiV Healthcare expanded its campaign for HIV prevention and treatment in the U.S. South, funding grassroots outreach projects worth more than $2.8 million. Report

> Big Pharma companies are eyeing government contracts in Brazil, wooed by the market share guarantees offered under the new partnerships. Report

And Finally... Sanofi ($SNY) and Regeneron ($REGN) said they started a new study of their experimental drug dupilumab in atopic dermatitis. Release

Suggested Articles

With drug-resistant bacteria on the rise, antibiotics have struggled to keep up. But with an FDA nod for Nabriva's Xenleta, some of that may change.

JAK drugs have run into safety issues, and if the label for AbbVie's Rinvoq is any indication, the FDA now believes those the issues are class-wide.

Disorder: The Rare Disease Film Festival is back and bigger than ever, set for a West Coast debut with 50 films this fall.